MA48475A - Procédés de fabrication de niraparib - Google Patents
Procédés de fabrication de niraparibInfo
- Publication number
- MA48475A MA48475A MA048475A MA48475A MA48475A MA 48475 A MA48475 A MA 48475A MA 048475 A MA048475 A MA 048475A MA 48475 A MA48475 A MA 48475A MA 48475 A MA48475 A MA 48475A
- Authority
- MA
- Morocco
- Prior art keywords
- niraparib
- manufacturing processes
- processes
- manufacturing
- niraparib manufacturing
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- PCHKPVIQAHNQLW-CQSZACIVSA-N niraparib Chemical compound N1=C2C(C(=O)N)=CC=CC2=CN1C(C=C1)=CC=C1[C@@H]1CCCNC1 PCHKPVIQAHNQLW-CQSZACIVSA-N 0.000 title 1
- 229950011068 niraparib Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/42—Separation; Purification; Stabilisation; Use of additives
- C07C303/44—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762489415P | 2017-04-24 | 2017-04-24 | |
| US201762489387P | 2017-04-24 | 2017-04-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA48475A true MA48475A (fr) | 2020-03-04 |
Family
ID=63919973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA048475A MA48475A (fr) | 2017-04-24 | 2018-04-24 | Procédés de fabrication de niraparib |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US11161834B2 (fr) |
| EP (1) | EP3615513B1 (fr) |
| JP (1) | JP7179014B2 (fr) |
| KR (1) | KR102582624B1 (fr) |
| CN (2) | CN118271233A (fr) |
| AU (2) | AU2018258274C1 (fr) |
| CA (1) | CA3060715C (fr) |
| ES (1) | ES2926255T3 (fr) |
| IL (1) | IL270068B (fr) |
| MA (1) | MA48475A (fr) |
| MX (1) | MX393879B (fr) |
| SG (1) | SG11201909807TA (fr) |
| TW (1) | TWI783993B (fr) |
| WO (1) | WO2018200517A1 (fr) |
| ZA (1) | ZA201906944B (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201811564QA (en) | 2016-06-29 | 2019-01-30 | Tesaro Inc | Methods of treating ovarian cancer |
| EP3600314A1 (fr) | 2017-03-27 | 2020-02-05 | Tesaro, Inc. | Compositions de niraparib |
| CN118271233A (zh) | 2017-04-24 | 2024-07-02 | 特沙诺有限公司 | 尼拉帕利的制造方法 |
| US12156872B2 (en) | 2017-05-09 | 2024-12-03 | Tesaro, Inc. | Combination therapies for treating cancer |
| CA3063715A1 (fr) | 2017-05-18 | 2018-11-22 | Tesaro, Inc. | Polytherapies pour le traitement du cancer |
| CA3076907A1 (fr) | 2017-09-26 | 2019-04-04 | Tesaro, Inc. | Formulations de niraparib |
| CN111372607A (zh) | 2017-09-30 | 2020-07-03 | 特沙诺有限公司 | 用于治疗癌症的联合疗法 |
| US11801240B2 (en) | 2017-10-06 | 2023-10-31 | Tesaro, Inc. | Combination therapies and uses thereof |
| WO2020072796A1 (fr) | 2018-10-03 | 2020-04-09 | Tesaro, Inc. | Formes cristallines d'une base libre de niraparib |
| CN112300074B (zh) * | 2019-08-02 | 2023-12-29 | 北京盈科瑞创新药物研究有限公司 | 一种吲唑甲酰胺类化合物及其制备方法和应用 |
| CN119156216A (zh) | 2022-02-15 | 2024-12-17 | 特沙诺有限公司 | 尼拉帕尼用于治疗脑癌的用途 |
| WO2024142096A1 (fr) * | 2022-12-29 | 2024-07-04 | Dr. Reddy’S Laboratories Limited | Procédé de préparation de tosylate de niraparib et de ses intermédiaires |
| WO2025017711A1 (fr) * | 2023-07-20 | 2025-01-23 | Natco Pharma Limited | Procédé amélioré pour la préparation de monohydrate de tosylate de niraparib |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| FI104465B (fi) | 1995-06-14 | 2000-02-15 | Valio Oy | Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö |
| JP4213771B2 (ja) | 1997-04-23 | 2009-01-21 | 株式会社カネカ | 光学活性アミノ化合物の製造方法 |
| EP1036198B1 (fr) | 1997-12-08 | 2012-09-26 | California Institute Of Technology | Procédé de préparation des séquences de polynucléotides et de polypeptides |
| JP4221100B2 (ja) | 1999-01-13 | 2009-02-12 | エルピーダメモリ株式会社 | 半導体装置 |
| GB0004297D0 (en) | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
| AU4964101A (en) | 2000-03-30 | 2001-10-15 | Maxygen Inc | In silico cross-over site selection |
| CN1854128B (zh) | 2001-04-24 | 2012-05-16 | 麻省理工学院 | 铜-催化的碳-杂原子键和碳-碳键的形成 |
| US7199147B2 (en) | 2001-06-12 | 2007-04-03 | Dainippon Sumitomo Pharma Co., Ltd. | Rho kinase inhibitors |
| NZ554722A (en) | 2004-09-29 | 2010-07-30 | Mitsubishi Tanabe Pharma Corp | 6-(Pyridinyl)-4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| CA2647545C (fr) | 2006-04-03 | 2016-02-23 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Utilisation de derives de benzotriazole et d'indazole amide substitue comme inhibiteurs de la poly(adp-ribose)polymerase (parp) |
| WO2008027466A1 (fr) | 2006-08-31 | 2008-03-06 | Schering Corporation | Derives d'hydantoine utiles en tant qu'agents antibacteriens |
| EP2805945B1 (fr) | 2007-01-10 | 2019-04-03 | MSD Italia S.r.l. | Indazoles substitués d'amide en tant qu'inhibiteurs PARP de poly(ADP-ribose)polymérase |
| EP2132322A4 (fr) | 2007-03-02 | 2013-02-20 | Richmond Chemical Corp | Procédé pour augmenter le rendement et améliorer la purification de produits provenant de réactions avec une transaminase |
| PE20081889A1 (es) * | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
| WO2008132142A2 (fr) | 2007-04-27 | 2008-11-06 | Ucb Pharma S.A. | Nouveaux dérivés hétérocycliques utiles pour le traitement des troubles du système nerveux central |
| JP5989965B2 (ja) | 2008-01-08 | 2016-09-07 | メルク シャープ エンド ドーム リミテッド | ２−｛４−［（３ｓ）−ピペリジン−３−イル］フェニル｝−２ｈ−インダゾール−７−カルボキサミドの薬学的に許容される塩 |
| EP2401366B1 (fr) | 2009-02-26 | 2013-12-18 | Codexis, Inc. | Biocatalyseurs transaminase |
| JP2010269667A (ja) | 2009-05-20 | 2010-12-02 | Alps Electric Co Ltd | 多回転角度検出装置 |
| US8932836B2 (en) | 2010-08-16 | 2015-01-13 | Codexis, Inc. | Biocatalysts and methods for the synthesis of (1R,2R)-2-(3,4-dimethoxyphenethoxy)cyclohexanamine |
| EP2649062B1 (fr) | 2010-11-30 | 2015-04-08 | Takeda Pharmaceutical Company Limited | Composes bicycliques en tant qu`inhibiteurs d'acetyle-coa-carboxylase (acc) |
| PT2673260T (pt) | 2011-02-08 | 2016-10-24 | Pfizer | Modulador do recetor de glucagon |
| US8802673B2 (en) | 2011-03-24 | 2014-08-12 | Hoffmann-La Roche Inc | Heterocyclic amine derivatives |
| US9073911B2 (en) | 2011-06-09 | 2015-07-07 | Hoffmann-La Roche Inc. | Pyrazole derivatives |
| US9580407B2 (en) | 2012-12-07 | 2017-02-28 | Merck Sharp & Dohme Corp. | Regioselective N-2 arylation of indazoles |
| US9738915B2 (en) | 2012-12-07 | 2017-08-22 | Merck Sharp & Dohme Corp. | Biocatalytic transamination process |
| EP3230472A4 (fr) | 2014-12-08 | 2018-06-13 | Myriad Genetics, Inc. | Méthodes et matériaux permettant de prédire une réaction au niraparib |
| SG11201811564QA (en) | 2016-06-29 | 2019-01-30 | Tesaro Inc | Methods of treating ovarian cancer |
| CN106496187A (zh) * | 2016-09-14 | 2017-03-15 | 陕西科技大学 | 一种制备PARP抑制剂Niraparib的合成方法 |
| CN106432055A (zh) * | 2016-09-17 | 2017-02-22 | 青岛辰达生物科技有限公司 | 一种尼拉帕布中间体4‑（哌啶‑3‑基）苯胺的制备方法 |
| CN106432057A (zh) * | 2016-09-17 | 2017-02-22 | 青岛云天生物技术有限公司 | 一种制备(3s)‑3‑(4‑氨基苯基)哌啶‑1‑甲酸叔丁酯的方法 |
| CN106432056A (zh) * | 2016-09-17 | 2017-02-22 | 青岛辰达生物科技有限公司 | 一种尼拉帕布中间体(3s)‑3‑(4‑氨基苯基)哌啶‑1‑甲酸叔丁酯的制备方法 |
| EP3600314A1 (fr) | 2017-03-27 | 2020-02-05 | Tesaro, Inc. | Compositions de niraparib |
| BR112019020191A2 (pt) | 2017-03-27 | 2020-04-22 | Tesaro Inc | formulações de niraparib |
| CN118271233A (zh) | 2017-04-24 | 2024-07-02 | 特沙诺有限公司 | 尼拉帕利的制造方法 |
| US12156872B2 (en) | 2017-05-09 | 2024-12-03 | Tesaro, Inc. | Combination therapies for treating cancer |
| CA3063715A1 (fr) | 2017-05-18 | 2018-11-22 | Tesaro, Inc. | Polytherapies pour le traitement du cancer |
| CA3076907A1 (fr) | 2017-09-26 | 2019-04-04 | Tesaro, Inc. | Formulations de niraparib |
| CN111372607A (zh) | 2017-09-30 | 2020-07-03 | 特沙诺有限公司 | 用于治疗癌症的联合疗法 |
| US11801240B2 (en) | 2017-10-06 | 2023-10-31 | Tesaro, Inc. | Combination therapies and uses thereof |
| EP3731866A1 (fr) | 2017-12-27 | 2020-11-04 | Tesaro Inc. | Méthodes de traitement du cancer |
| CA3090479A1 (fr) | 2018-02-05 | 2019-08-08 | Tesaro, Inc | Formulations pediatriques de niraparib et procedes de traitement pediatrique |
-
2018
- 2018-04-24 CN CN202410234039.3A patent/CN118271233A/zh active Pending
- 2018-04-24 IL IL270068A patent/IL270068B/en unknown
- 2018-04-24 US US16/608,059 patent/US11161834B2/en active Active
- 2018-04-24 ES ES18790167T patent/ES2926255T3/es active Active
- 2018-04-24 JP JP2019557567A patent/JP7179014B2/ja active Active
- 2018-04-24 SG SG11201909807T patent/SG11201909807TA/en unknown
- 2018-04-24 WO PCT/US2018/029131 patent/WO2018200517A1/fr not_active Ceased
- 2018-04-24 EP EP18790167.3A patent/EP3615513B1/fr active Active
- 2018-04-24 CA CA3060715A patent/CA3060715C/fr active Active
- 2018-04-24 MA MA048475A patent/MA48475A/fr unknown
- 2018-04-24 AU AU2018258274A patent/AU2018258274C1/en active Active
- 2018-04-24 KR KR1020197034673A patent/KR102582624B1/ko active Active
- 2018-04-24 TW TW107113922A patent/TWI783993B/zh active
- 2018-04-24 CN CN201880040321.0A patent/CN110753684A/zh active Pending
- 2018-04-24 MX MX2019012658A patent/MX393879B/es unknown
-
2019
- 2019-10-22 ZA ZA2019/06944A patent/ZA201906944B/en unknown
-
2021
- 2021-08-09 AU AU2021215116A patent/AU2021215116B2/en active Active
- 2021-10-29 US US17/452,928 patent/US11629137B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| IL270068B (en) | 2022-06-01 |
| EP3615513B1 (fr) | 2022-07-20 |
| AU2021215116B2 (en) | 2022-12-01 |
| AU2018258274A1 (en) | 2019-11-14 |
| BR112019022320A2 (pt) | 2020-05-26 |
| AU2018258274B2 (en) | 2021-05-13 |
| CA3060715A1 (fr) | 2018-11-01 |
| US20220041575A1 (en) | 2022-02-10 |
| AU2018258274C1 (en) | 2021-12-02 |
| EP3615513A1 (fr) | 2020-03-04 |
| KR102582624B1 (ko) | 2023-09-22 |
| NZ758948A (en) | 2024-04-26 |
| US20200055837A1 (en) | 2020-02-20 |
| AU2021215116A1 (en) | 2021-08-26 |
| US11161834B2 (en) | 2021-11-02 |
| ES2926255T3 (es) | 2022-10-24 |
| TWI783993B (zh) | 2022-11-21 |
| JP7179014B2 (ja) | 2022-11-28 |
| EP3615513A4 (fr) | 2020-12-09 |
| JP2020517668A (ja) | 2020-06-18 |
| MX393879B (es) | 2025-03-24 |
| ZA201906944B (en) | 2023-03-29 |
| CN110753684A (zh) | 2020-02-04 |
| US11629137B2 (en) | 2023-04-18 |
| WO2018200517A1 (fr) | 2018-11-01 |
| CA3060715C (fr) | 2024-10-01 |
| SG11201909807TA (en) | 2019-11-28 |
| TW201841889A (zh) | 2018-12-01 |
| KR20200021456A (ko) | 2020-02-28 |
| CN118271233A (zh) | 2024-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA48475A (fr) | Procédés de fabrication de niraparib | |
| MA51792A (fr) | Procédés de fabrication de lymphocytes t | |
| EP3606847A4 (fr) | Installation et procédés de fabrication automatisée | |
| DE102016200026B8 (de) | Wafer-Herstellungsverfahren | |
| MA43711A (fr) | Procédés de production de l-glufosinate | |
| FR3046093B1 (fr) | Atelier de fabrication additive | |
| EP3487681A4 (fr) | Fabrication additive | |
| EP3383599A4 (fr) | Préhenseur de robot | |
| EP3417092C0 (fr) | Procédés de fabrication de matériaux en graphène | |
| EP3366271A4 (fr) | Procédé de fabrication de film | |
| EP3366270A4 (fr) | Procédé de fabrication de film | |
| EP3504217A4 (fr) | Procédés de couplage croisé | |
| EP3551458C0 (fr) | Fabrication additive | |
| IL263618A (en) | Tracked all-terrain vehicle | |
| MA43271A (fr) | Formulations améliorées de déférasirox et leurs procédés de fabrication | |
| EP3663014A4 (fr) | Procédé de fabrication de cannettes, et procédé de fabrication de cannettes | |
| EP3679232A4 (fr) | Fabrication de panneau de réduction acoustique | |
| EP3450114A4 (fr) | Robot | |
| EP3694961A4 (fr) | Fluides de fabrication | |
| EP3450118A4 (fr) | Robot | |
| EP3499556A4 (fr) | Appareil de fabrication de semi-conducteurs | |
| EP3692808A4 (fr) | Procédé de fabrication de pâtes sèches | |
| DK3307216T3 (da) | Termoformbare halvstive ortoser | |
| EP3410828A4 (fr) | Procédé de fabrication de film | |
| EP3704551C0 (fr) | Procédé de production distribuée |